dodecylmethyl sulfide | 126841-38-1

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: dodecylmethyl sulfide
• 英文别名: Di-tridecyl-sulfid；ditridecylsulfane；Dodecylmethylsulfide；1-tridecylsulfanyltridecane
• CAS: 126841-38-1
• 化学式: C₂₆H₅₄S
• 分子量: 398.781
• InChiKey: ODKKURSBDDZKCL-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  13.1
• 重原子数：
  27
• 可旋转键数：
  24
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  25.3
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] 2, 4- DI (PHENYLAMINO) PYRIMIDINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS<br/>[FR] 2,4-DI(PHENYLAMINO)PYRIMIDINES UTILISEES POUR TRAITER DES MALADIES NEOPLASIQUES, DES TROUBLES INFLAMMATOIRES ET DES TROUBLES DU SYSTEME IMMUNITAIRE
  申请人：NOVARTIS AG

  公开号：WO2004080980A1

  公开（公告）日：2004-09-23

  Novel pyrimidine derivatives of formula (I), to processes for their production, their use as pharmaceuticals in the treatment of neoplastic diseases, inflammatory and immune system disorders and to pharmaceutical compositions comprising them.

  化合物(I)的新型嘧啶衍生物，其生产方法，它们作为药物在治疗肿瘤性疾病、炎症和免疫系统紊乱中的应用，以及包含它们的药物组合物。
• [EN] C-4" POSITION SUBSTITUTED MACROLIDE DERIVATIVE<br/>[FR] DÉRIVÉ DE MACROLIDE SUBSTITUÉ EN POSITION C-4"
  申请人：TAISHO PHARMA CO LTD

  公开号：WO2012115256A1

  公开（公告）日：2012-08-30

  A macrolide compound represented by the formula (I) effective against erythromycin resistant bacteria (for example, resistant pneumococci, streptococci and mycoplasmas).

  一种由化学式（I）表示的大环内酯化合物，对红霉素耐药细菌有效（例如，耐药的肺炎球菌、链球菌和支原体）。
• [EN] 2, 4-PYRIMIDINEDIAMINES USEFUL IN THE TREATMENT OF NEOPLASTIC DISEASES, INFLAMMATORY AND IMMUNE SYSTEM DISORDERS<br/>[FR] 2, 4-PYRIMIDINE DIAMINES UTILES DANS LE CADRE DU TRAITEMENT DE MALADIES NEOPLASIQUES, DE TROUBLES INFLAMMATOIRES ET DE TROUBLES DU SYSTEME IMMUNITAIRE
  申请人：NOVARTIS AG

  公开号：WO2005016894A1

  公开（公告）日：2005-02-24

  Novel pyrimidine derivatives of formula (I) Wherein R is selected from C16-10 aryl, C5-10heteroaryl, C3-12cycloalkyl and C3-10heterocycloalkyl; R0-R6 as described herein; and their use for the manufacture of a medicament for the treatment or prevention of a disease wich responds to inhibition of FAK and/or ALK and/or ZAP-70 and/or IGF-IR.

  化合物式(I)中的新型嘧啶衍生物，其中R从C16-10芳基，C5-10杂芳基，C3-12环烷基和C3-10杂环烷基中选择；R0-R6如此处所述；以及它们的用途，制造用于治疗或预防对FAK和/或ALK和/或ZAP-70和/或IGF-IR抑制有反应的疾病的药物。
• 2,4-Di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
  申请人：Garcia-Echeverria Carlos

  公开号：US20060247241A1

  公开（公告）日：2006-11-02

  Novel pyrimidine derivatives of formula I to process for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them

  式I的新型嘧啶衍生物的制备方法，其用途作为药物以及包含它们的药物组合物的制备方法。
• 2, 4-Pyrimidinediamines Useful In The Treatment Of Neoplastic Diseases, Inflammatory And Immune System Disorders
  申请人：Garcia-Echeverria Carlos

  公开号：US20080132504A1

  公开（公告）日：2008-06-05

  Novel pyrimidine derivatives of formula I to processes for their production, their use as pharmaceuticals and to pharmaceutical compositions comprising them

  式I的新型嘧啶衍生物及其制备方法，它们的药用价值以及包含它们的药物组合物。